ArticleThe Journal of antimicrobial chemotherapy2023

In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates.

Christophe Le Terrier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.